Features of Lung Cancer Treatment–Related AML
Therapy-related AML after lung cancer is rare, but is associated with poor prognosis.
News
Simple Flow-Based Prognostic Score Developed for Patients With MDS
Although other flow cytometry–based prognostic scores have been proposed in the setting of MDS, their complexity has limited their clinical use.
Cardiomyopathy Screenings Low Among Young Cancer Survivors Exposed to Chest Radiation or Anthracyclines
Electronic medical records for more than 3500 survivors of pediatric malignancies were reviewed to determine number for whom cardiomyopathy screenings were recommended and rate of compliance with that recommendation.
Increased Mortality Risk in Patients With Cancer Experiencing the Death of a Child
Population-based study evaluated survival outcomes for patients with cancer diagnosed over a 41-year period.
Risk Factors for Early Relapse of DLBCL After CAR-T Therapy
Nearly half of all relapses occurred within the first month of CAR-T infusion.
HCT Deemed More Favorable for MDS That Is High Risk
HCT resulted in a lower risk of death among patients with high risk disease or if performed shortly after diagnosis, according to an observational study.
Grants Awarded to Help VA Centers Enroll Veterans Into Cancer Trials
Two VA medical centers were each awarded one-time $50,000 grant funding to help them enroll veterans with cancer into clinical trials.
Chemotherapy-Free Combination Therapy Targeted to the Epigenome in PTCL
Peripheral T-cell lymphoma is characterized by extensive epigenetic dysregulation.
Venous Thromboembolism Risk Steadily Increasing in Cancer
The risk for venous thromboembolism is steadily increasing among patients with cancer compared with the general population.
Does Type of Radiation Therapy in Hodgkin Lymphoma Treatment Affect Lung Toxicity?
Researchers examined data from patients who were treated for Hodgkin lymphoma between 2009 and 2013 who had received radiation therapy as part of their treatment.
Conditioning With Alkylating Agents Prior to Transplant for Myelofibrosis
Patients with myelofibrosis conditioned with 2 alkylating agents may have better transplant outcomes compared with patients receiving 1 alkylating agent.
New Dosing Option Approved for Imfinzi in NSCLC, Bladder Cancer
The approval was based on data from several clinical trials, including the phase 3 PACIFIC trial and the phase 3 CASPIAN trial.
Effectiveness of Influenza A Vaccine May Be Diminished in Patients With MPNs
Researchers report on status of immune response to influenza A vaccination, particularly memory cell clusters, in patients with myeloproliferative neoplasms.
Trends in End-of-Life Care in Women With Metastatic Breast Cancer
A recent analysis of insurance claims data revealed trends in ED visits, ICU visits, hospitalizations, and antineoplastic treatment at the end of life in this population.
Venous Thromboembolism Rates in Patients With SARS-CoV-2 Infection
In a new study, researchers reported on the frequency of VTE among more than 6000 patients who tested positive for infection with SARS-CoV-2.
Postmarketing Observational Study of Tisagenlecleucel for ALL or NHL Yields Promising Results
Researchers report on results with CAR-T therapy in real-world populations of patients with ALL or NHL.
Pfizer, BioNTech to Submit EUA Request for COVID-19 Vaccine Candidate
Pfizer and BioNTech will submit an Emergency Use Authorization (EUA) request to the FDA for their mRNA-based vaccine candidate BNT162b2 against COVID-19.
Authors at Gynecologic Oncology Meeting Fail to Disclose Industry Relationships
Most study authors at the 2019 Society of Gynecologic Oncology Annual Meeting failed to disclose industry relationships, a study found.
Predictors of Worse Outcomes Identified for Patients With COVID-19 and Myeloma
Age, high-risk disease, renal disease, and active or progressive disease were predictive of worse outcomes for patients with multiple myeloma and COVID-19.
Managing Oral Mucosal AEs of Adjuvant Endocrine Therapy in Patients With Breast Cancer
A literature review showed strategies for managing oral mucosal AEs in this patient population, including the role of dentists in a multidisciplinary team.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Web Exclusives
